154 related articles for article (PubMed ID: 38133687)
21. Prospective comparison of CT and 18F-FDG PET/MRI in N and M staging of primary breast cancer patients: Initial results.
Bruckmann NM; Kirchner J; Morawitz J; Umutlu L; Herrmann K; Bittner AK; Hoffmann O; Mohrmann S; Ingenwerth M; Schaarschmidt BM; Li Y; Stang A; Antoch G; Sawicki LM; Buchbender C
PLoS One; 2021; 16(12):e0260804. PubMed ID: 34855886
[TBL] [Abstract][Full Text] [Related]
22. Machine learning classification of texture features of MRI breast tumor and peri-tumor of combined pre- and early treatment predicts pathologic complete response.
Hussain L; Huang P; Nguyen T; Lone KJ; Ali A; Khan MS; Li H; Suh DY; Duong TQ
Biomed Eng Online; 2021 Jun; 20(1):63. PubMed ID: 34183038
[TBL] [Abstract][Full Text] [Related]
23. Near-Infrared Diffuse Optical Imaging for Early Prediction of Breast Cancer Response to Neoadjuvant Chemotherapy: A Comparative Study Using 18F-FDG PET/CT.
Ueda S; Yoshizawa N; Shigekawa T; Takeuchi H; Ogura H; Osaki A; Saeki T; Ueda Y; Yamane T; Kuji I; Sakahara H
J Nucl Med; 2016 Aug; 57(8):1189-95. PubMed ID: 26940765
[TBL] [Abstract][Full Text] [Related]
24. Machine learning on MRI radiomic features: identification of molecular subtype alteration in breast cancer after neoadjuvant therapy.
Liu HQ; Lin SY; Song YD; Mai SY; Yang YD; Chen K; Wu Z; Zhao HY
Eur Radiol; 2023 Apr; 33(4):2965-2974. PubMed ID: 36418622
[TBL] [Abstract][Full Text] [Related]
25. Axillary lymph node response to neoadjuvant systemic therapy with dedicated axillary hybrid
de Mooij CM; Samiei S; Mitea C; Lobbes MBI; Kooreman LFS; Heuts EM; Beets-Tan RGH; van Nijnatten TJA; Smidt ML
Clin Radiol; 2022 Oct; 77(10):e732-e740. PubMed ID: 35850866
[TBL] [Abstract][Full Text] [Related]
26. Value of the Application of CE-MRI Radiomics and Machine Learning in Preoperative Prediction of Sentinel Lymph Node Metastasis in Breast Cancer.
Zhu Y; Yang L; Shen H
Front Oncol; 2021; 11():757111. PubMed ID: 34868967
[TBL] [Abstract][Full Text] [Related]
27. A machine learning model based on ultrasound image features to assess the risk of sentinel lymph node metastasis in breast cancer patients: Applications of scikit-learn and SHAP.
Zhang G; Shi Y; Yin P; Liu F; Fang Y; Li X; Zhang Q; Zhang Z
Front Oncol; 2022; 12():944569. PubMed ID: 35957890
[TBL] [Abstract][Full Text] [Related]
28. [Comparing prediction performances of
Vincent L; Jankowski C; Arnould L; Coudert B; Rouzier R; Reyal F; Humbert O; Coutant C
Gynecol Obstet Fertil Senol; 2020 Sep; 48(9):679-686. PubMed ID: 32205278
[TBL] [Abstract][Full Text] [Related]
29. Prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer using radiomics of pretreatment dynamic contrast-enhanced MRI.
Yoshida K; Kawashima H; Kannon T; Tajima A; Ohno N; Terada K; Takamatsu A; Adachi H; Ohno M; Miyati T; Ishikawa S; Ikeda H; Gabata T
Magn Reson Imaging; 2022 Oct; 92():19-25. PubMed ID: 35636571
[TBL] [Abstract][Full Text] [Related]
30. Neoadjuvant chemotherapy in breast cancer: prediction of pathologic response with PET/CT and dynamic contrast-enhanced MR imaging--prospective assessment.
Tateishi U; Miyake M; Nagaoka T; Terauchi T; Kubota K; Kinoshita T; Daisaki H; Macapinlac HA
Radiology; 2012 Apr; 263(1):53-63. PubMed ID: 22438441
[TBL] [Abstract][Full Text] [Related]
31. FDG PET/CT radiomics as a tool to differentiate between reactive axillary lymphadenopathy following COVID-19 vaccination and metastatic breast cancer axillary lymphadenopathy: a pilot study.
Eifer M; Pinian H; Klang E; Alhoubani Y; Kanana N; Tau N; Davidson T; Konen E; Catalano OA; Eshet Y; Domachevsky L
Eur Radiol; 2022 Sep; 32(9):5921-5929. PubMed ID: 35385985
[TBL] [Abstract][Full Text] [Related]
32. 2-fluoro-2-deoxy-D-glucose positron emission tomography versus conventional imaging for the diagnosis of breast cancer and lymph node metastases.
Shao M; Zi J; Wen G
J Cancer Res Ther; 2018 Sep; 14(Supplement):S661-S666. PubMed ID: 30249884
[TBL] [Abstract][Full Text] [Related]
33. A machine learning tool to improve prediction of mediastinal lymph node metastases in non-small cell lung cancer using routinely obtainable [
Rogasch JMM; Michaels L; Baumgärtner GL; Frost N; Rückert JC; Neudecker J; Ochsenreither S; Gerhold M; Schmidt B; Schneider P; Amthauer H; Furth C; Penzkofer T
Eur J Nucl Med Mol Imaging; 2023 Jun; 50(7):2140-2151. PubMed ID: 36820890
[TBL] [Abstract][Full Text] [Related]
34. Breast Tumor Characterization Using [
Krajnc D; Papp L; Nakuz TS; Magometschnigg HF; Grahovac M; Spielvogel CP; Ecsedi B; Bago-Horvath Z; Haug A; Karanikas G; Beyer T; Hacker M; Helbich TH; Pinker K
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33809057
[No Abstract] [Full Text] [Related]
35. A multiparametric [
Leithner D; Horvat JV; Bernard-Davila B; Helbich TH; Ochoa-Albiztegui RE; Martinez DF; Zhang M; Thakur SB; Wengert GJ; Staudenherz A; Jochelson MS; Morris EA; Baltzer PAT; Clauser P; Kapetas P; Pinker K
Eur J Nucl Med Mol Imaging; 2019 Aug; 46(9):1878-1888. PubMed ID: 31197455
[TBL] [Abstract][Full Text] [Related]
36. FDG-PET/CT and MRI for Evaluation of Pathologic Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer: A Meta-Analysis of Diagnostic Accuracy Studies.
Sheikhbahaei S; Trahan TJ; Xiao J; Taghipour M; Mena E; Connolly RM; Subramaniam RM
Oncologist; 2016 Aug; 21(8):931-9. PubMed ID: 27401897
[TBL] [Abstract][Full Text] [Related]
37. Multicenter clinical radiomics-integrated model based on [
Zhang L; Pan H; Liu Z; Gao J; Xu X; Wang L; Wang J; Tang Y; Cao X; Kan Y; Wen Z; Chen J; Huang D; Chen S; Li Y
Eur Radiol; 2023 Feb; 33(2):872-883. PubMed ID: 35984514
[TBL] [Abstract][Full Text] [Related]
38. Combined use of ¹⁸F-FDG PET/CT and MRI for response monitoring of breast cancer during neoadjuvant chemotherapy.
Pengel KE; Koolen BB; Loo CE; Vogel WV; Wesseling J; Lips EH; Rutgers EJ; Valdés Olmos RA; Vrancken Peeters MJ; Rodenhuis S; Gilhuijs KG
Eur J Nucl Med Mol Imaging; 2014 Aug; 41(8):1515-24. PubMed ID: 24777490
[TBL] [Abstract][Full Text] [Related]
39. Multi-Parametric MRI-Based Radiomics Models for Predicting Molecular Subtype and Androgen Receptor Expression in Breast Cancer.
Huang Y; Wei L; Hu Y; Shao N; Lin Y; He S; Shi H; Zhang X; Lin Y
Front Oncol; 2021; 11():706733. PubMed ID: 34490107
[TBL] [Abstract][Full Text] [Related]
40. Staging/restaging performance of F18-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in breast cancer: A review and meta-analysis.
Lin CY; Lin CL; Kao CH
Eur J Radiol; 2018 Oct; 107():158-165. PubMed ID: 30292261
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
